Meditoxin Botox Botulinum Toxin Type A 100U

Meditoxin is botulinum A developed by Medy Tox Korea Limited that approved by KDA on 2004 which had been proved a better effect than Botox .
The most common complications following injection include bruising at the injection site, mild headache, dry eye, drooping eyelids and uneven look of skin. Most of these results are temporary, undesired effects will fade and then disappear over time.
Adverse effects are higher when treating medical ailments, a combination of the higher doses administered and higher risk factors associated with the specific illness being treated. Rarely, it can cause spread beyond the site of injection. If it travels to the respiratory muscles, respiratory paralysis can occur.

Duration of effects:
The effect of Meditoxin treatment lasts for 4-6 months. The treatment needs to be repeated after the effect wears off. Repeated treatments do not have any harmful effects.
Adverse effects:
Toxin when administered in the right areas in correct dosage does not cause any harm. The safety record for this treatment is high. Under correction can happen and can be easily corrected.

Similar to Botox, it relaxes the muscles into which it has been injected, delivering a fast, temporary treatment of facial wrinkles and clinical conditions such as blepharospasm, pediatric cerebral palsy and hyperhidrosis.